Lumantas, Kim Daniell F.

HRN: 21-53-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CEFTRIAXONE 1G (VIAL)
07/09/2022
07/15/2022
IV DRIP
2 Grams
Q24
Seizure Disroder
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: